by New research published in the journal “Cancer Research” sheds light on the potential link between non-alcoholic fatty liver disease (NAFLD) and the progression of breast cancer. This finding aligns with the long-held theory in Traditional Chinese Medicine (TCM) that liver health is closely related to breast health.
According to the study, NAFLD, which is characterized by the accumulation of fat in liver cells, can lead to the production of specific molecules called ceramides. These ceramides have been shown to promote breast cancer cell growth and metastasis.
The researchers analyzed data from over 1,000 women, revealing that those with NAFLD had a higher risk of developing more aggressive forms of breast cancer. Furthermore, they found that the presence of NAFLD significantly worsened the prognosis for breast cancer patients.
These findings add to the growing body of evidence supporting the TCM theory that liver health plays a crucial role in breast health. The researchers emphasized the importance of addressing both conditions, as managing NAFLD could potentially improve breast cancer outcomes.
In conclusion, the latest research provides compelling evidence for the connection between fatty liver and breast cancer. By understanding this link, healthcare professionals can develop more effective strategies for preventing and treating both conditions, ultimately improving patient outcomes.
*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
